Loading...
XLON
WWH
Market cap1.76bUSD
Oct 07, Last price  
371.50GBP
1D
0.68%
1Q
-5.83%
Jan 2017
75.48%
Name

Worldwide Healthcare Trust PLC

Chart & performance

D1W1MN
XLON:WWH chart
P/E
11.76
P/S
106.35
EPS
0.32
Div yield, %
0.65%
Shrs. gr., 5y
-6.53%
Rev. gr., 5y
-51.85%
Revenues
13m
P
-29,914,000-11,930,00068,481,00085,894,00015,312,00063,311,000113,954,000133,930,000342,158,000-81,112,000252,021,00032,195,000172,070,00096,258,000484,372,000-132,467,000-2,233,000235,192,000-198,056,00012,533,000
Net income
113m
P
-36,244,000-16,520,00064,263,00079,402,00010,676,00055,312,000112,206,000132,123,000338,687,000-84,629,000248,369,00027,179,000166,240,00090,776,000477,018,000-141,526,000-8,787,000201,162,000-209,768,000113,363,000
CFO
-3m
L+113.92%
3,404,0003,585,000479,000-5,823,00000002,115,000931,000-13,329,0005,394,0002,262,000-1,544,000-3,303,000
Dividend
Jun 11, 20261.7 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.

Key people

Martin G. Smith
Independent Non-Executive Chairman of the Board · since 2008
Sven H. Borho
Non-Executive Director · since 2018
Sarah C. Bates
Independent Non-Executive Director · since 2013
Senior Independent Non-Executive Director · since 2016
Doug McCutcheon
Independent Non-Executive Director · since 2012
Humphrey van der Klugt
Independent Non-Executive Director · since 2016
IPO date
Apr 06, 1995
Employees
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
1 WOOD STREET
LONDON, LND EC2V 7WS
GB
Previous name
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT